MeSH tree: C01.925.256.466.930.750
The idea that you can "catch" shingles is one of the more common misconceptions I hear from patients who arrive worried they've got it. Often, they've recently been near a child with chickenpox or someone else with shingles, ...
Oct 14, 2025
0
17
A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence.
Oct 13, 2025
0
46
In an expert consensus statement issued by the American College of Cardiology and published online Aug. 26 in the Journal of the American College of Cardiology, guidelines are presented for vaccination against respiratory ...
Oct 2, 2025
0
19
Two countries, two different approaches to protecting children from chickenpox. While the UK prepares to introduce a combined vaccine covering measles, mumps, rubella and chickenpox (MMRV) in a single jab, the US is moving ...
Sep 29, 2025
0
19
Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute myocardial infarction, and stroke among adults aged 50 years or older, according to a study published ...
Aug 19, 2025
0
27
For almost 40 years, people who suspect they've been harmed by a vaccine have been able to turn to a little-known system called the Vaccine Injury Compensation Program—often simply called the vaccine court.
Aug 18, 2025
2
15
Vaccination against shingles increased among adults age 50 and older in the U.S. during the COVID-19 pandemic, but not equally across all population groups. That's the key finding from a new study my colleagues and I published ...
Aug 4, 2025
0
14
The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster).
Jul 22, 2025
0
14
A recent study analyzes the extent to which HIV tests are conducted following the diagnosis of an HIV indicator condition (IC) in primary care, as recommended by the World Health Organization and the European Centre for Disease ...
Jul 1, 2025
0
19
A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in the following 18 months. ...
Jun 26, 2025
0
142
